MYC and neoplasm: Along the same line, recent data demonstrate that myelocytomatosis oncogene (c-Myc) is a downstream target gene of the ERK1/2 signaling pathway, and disruption of the ERK1/2-c-Myc signaling pathway within tumor endothelial cells is sufficient to halt tumor enlargement [42].